Increased brain-specific MiR-9 and MiR-124 in the serum exosomes of acute ischemic stroke patients

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Ji, Qiuhong ^a,b   Ji, Yuhua ^b,c   Peng, Jingwen ^b   Zhou, Xin ^c   Chen, Xinya ^b   Zhao, Heng ^d   Xu, Tian ^b   Chen, Ling ^e   Xu, Yun ^a  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b NANTONG UNIVERSITY   (China)

^c JINAN UNIVERSITY   (China)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; MICRORNA 124; MICRORNA 9;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD LEVEL; BRAIN DAMAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; DISEASE SEVERITY; EXOSOMAL MICRORNA 124 BLOOD LEVEL; EXOSOMAL MICRORNA 9 BLOOD LEVEL; EXOSOME; FEMALE; GOLD STANDARD; HUMAN; HUMAN CELL; INTERLEUKIN 6 BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NANOPARTICLE TRACKING ANALYSIS; NATIONAL INSTITUTES OF HEALTH STROKE SCALE SCORE; PRECIPITATION; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RATING SCALE; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; RNA ANALYSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STROKE PATIENT; TRANSMISSION ELECTRON MICROSCOPY; VOLUNTEER; WESTERN BLOTTING;

EID: 84991790341     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0163645     Document Type: Article

References (39)

1. Jickling GC, Sharp FR. Biomarker panels in ischemic stroke. Stroke; a journal of cerebral circulation. 2015; 46(3):915-20. doi: 10.1161/STROKEAHA.114.005604 PMID: 25657186; PubMed Central PMCID: PMC4342265.
2. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. The New England journal of medicine. 2009; 361(9):858-67. doi: 10.1056/NEJMoa0900428 PMID: 19710484.
3. Bartel DP MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. PMID: 14744438.
4. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Current biology: CB. 2002; 12(9):735-9. PMID: 12007417.
5. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. The microRNA spectrum in 12 body fluids. Clinical chemistry. 2010; 56(11):1733-41. doi: 10.1373/clinchem.2010.147405 PMID: 20847327.
6. Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circulation research. 2012; 110(3):483-95. doi: 10.1161/CIRCRESAHA.111.247452 PMID: 22302755.
7. Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, et al. Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clinical chemistry. 2009; 55(11):1977-83. doi: 10.1373/clinchem.2009.131797 PMID: 19745058.
8. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature cell biology. 2007; 9(6):654-9. doi: 10.1038/ncb1596 PMID: 17486113.
9. Colombo E, Borgiani B, Verderio C, Furlan R. Microvesicles: novel biomarkers for neurological disorders. Frontiers in physiology. 2012; 3:63. doi: 10.3389/fphys.2012.00063 PMID: 22479250; PubMed Central PMCID: PMC3315111.
10. Weng H, Shen C, Hirokawa G, Ji X, Takahashi R, Shimada K, et al. PlasmamiR-124asa biomarker for cerebral infarction. Biomedical research. 2011; 32(2):135-41. PMID: 21551949.
11. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A. Analysis of circulating microRNA: preanalytical and analytical challenges. Clinical chemistry. 2011; 57(6):833-40. doi: 10.1373/clinchem.2010.157198 PMID: 21487102.
12. Landry P, Plante I, Ouellet DL, Perron MP, Rousseau G, Provost P. Existence of a microRNA pathway in anucleate platelets. Nature structural & molecular biology. 2009; 16(9):961-6. doi: 10.1038/nsmb.1651 PMID: 19668211; PubMed Central PMCID: PMC2911476.
13. Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current protocols in cell biology/editorial board, Juan S Bonifacino[etal]. 2006;Chapter3:Unit3 22. doi: 10.1002/0471143030.cb0322s30 PMID: 18228490.
14. Taylor DD, Zacharias W, Gercel-Taylor C. Exosome isolation for proteomic analyses and RNA profiling. Methods in molecular biology. 2011; 728:235-46. doi: 10.1007/978-1-61779-068-3-15 PMID: 21468952.
15. Lotvall J, Hill AF, Hochberg F, Buzas EI, Di Vizio D, Gardiner C, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. Journal of extracellular vesicles. 2014; 3:26913. doi: 10.3402/jev.v3.26913 PMID: 25536934; PubMed Central PMCID: PMC4275645.
16. Li M, Zeringer E, Barta T, Schageman J, Cheng A, Vlassov AV. Analysis of the RNA content of the exosomes derived from blood serum and urine and its potential as biomarkers. Philosophical Transactions of the Royal Society B: Biological Sciences. 2014; 369(1652):20130502.
17. Thijs VN, Lansberg MG, Beaulieu C, Marks MP, Moseley ME, Albers GW. Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariable analysis. Stroke; a journal of cerebral circulation. 2000; 31(11):2597-602. PMID: 11062281.
18. Kwan J, Horsfield G, Bryant T, Gawne-Cain M, Durward G, Byrne CD, et al. IL-6 is a predictive biomarker for stroke associated infection and future mortality in the elderly after an ischemic stroke. Experimental gerontology. 2013; 48(9):960-5. doi: 10.1016/j.exger.2013.07.003 PMID: 23872300.
19. Waje-Andreassen U, Krakenes J, Ulvestad E, Thomassen L, Myhr KM, Aarseth J, et al. IL-6: an early marker for outcome in acute ischemic stroke. Acta neurologica Scandinavica. 2005; 111(6):360-5. doi: 10.1111/j.1600-0404.2005.00416.x PMID: 15876336.
20. Whiteley W, Jackson C, Lewis S, Lowe G, Rumley A, Sandercock P, et al. Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS medicine. 2009; 6(9):e1000145. doi: 10.1371/journal.pmed.1000145 PMID: 19901973; PubMed Central PMCID: PMC2730573.
21. Jung KH, Chu K, Lee ST, Park HK, Bahn JJ, Kim DH, et al. Circulating endothelial microparticles as a marker of cerebrovascular disease. Annals of neurology. 2009; 66(2):191-9. doi: 10.1002/ana.21681 PMID: 19743467.
22. Kuriyama N, Nagakane Y, Hosomi A, Ohara T, Kasai T, Harada S, et al. Evaluation of factors associated with elevated levels of platelet-derived microparticles in the acute phase of cerebral infarction. Clinical and applied thrombosis/hemostasis: official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 2010; 16(1):26-32. doi: 10.1177/1076029609338047 PMID: 19671561.
23. Pospichalova V, Svoboda J, Dave Z, Kotrbova A, Kaiser K, Klemova D, et al. Simplified protocol for flow cytometry analysis of fluorescently labeled exosomes and microvesicles using dedicated flow cytometer. Journal of extracellular vesicles. 2015; 4:25530. doi: 10.3402/jev.v4.25530 PMID: 25833224; PubMed Central PMCID: PMC4382613.
24. Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer science. 2010; 101(10):2087-92. doi: 10.1111/j.1349-7006.2010.01650.x PMID: 20624164.
25. Long G, Wang F, Li H, Yin Z, Sandip C, Lou Y, et al. Circulating miR-30a, miR-126and let-7bas biomarker for ischemic stroke in humans. BMC neurology. 2013; 13:178. doi: 10.1186/1471-2377-13-178 PMID: 24237608; PubMed Central PMCID: PMC3840584.
26. Peng G, Yuan Y, Wu S, He F, Hu Y, Luo B. MicroRNA let-7e Is a Potential Circulating Biomarker of Acute Stage Ischemic Stroke. Translational stroke research. 2015; 6(6):437-45. doi: 10.1007/s12975-015-0422-x PMID: 26415639.
27. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circulation research. 2009; 105(2):158-66. doi: 10.1161/CIRCRESAHA.109.197517 PMID: 19542014; PubMed Central PMCID: PMC2728297.
28. Kent OA, McCall MN, Cornish TC, Halushka MK. Lessons from miR-143/145: the importance of cell-type localization of miRNAs. Nucleic acids research. 2014; 42(12):7528-38. doi: 10.1093/nar/gku461 PMID: 24875473; PubMed Central PMCID: PMC4081080.
29. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer prevention research. 2012; 5 (3):492-7. doi: 10.1158/1940-6207.CAPR-11-0370 PMID: 22158052; PubMed Central PMCID: PMC4186243.
30. Coolen M, Katz S, Bally-Cuif L. miR-9: a versatile regulator of neurogenesis. Frontiers in cellular neuroscience. 2013; 7:220. doi: 10.3389/fncel.2013.00220 PMID: 24312010; PubMed Central PMCID: PMC3834235.
31. Rainer TH, Leung LY, Chan CP, Leung YK, Abrigo JM, Wang D, et al. Plasma miR-124-3pand miR-16 concentrations as prognostic markers in acute stroke. Clinical biochemistry. 2016. doi: 10.1016/j.clinbiochem.2016.02.016 PMID: 26968104.
32. Hachisuka S, Kamei N, Ujigo S, Miyaki S, Yasunaga Y, Ochi M. Circulating microRNAs as biomarkers for evaluating the severity of acute spinal cord injury. Spinal cord. 2014; 52(8):596-600. doi: 10.1038/sc.2014.86 PMID: 24891009.
33. ∗ and miR-384-5pas potential indicators for trimethyltin-induced neurotoxicity. Toxicologic pathology. 2015; 43 (2):198-208. doi: 10.1177/0192623314530533 PMID: 24777749.
34. Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PloS one. 2012; 7(3):e30679. doi: 10.1371/journal.pone.0030679 PMID: 22427800; PubMed Central PMCID: PMC3302865.
35. Taylor DD, Gercel-Taylor C. Exosome platform for diagnosis and monitoring of traumatic brain injury. Philosophical transactions of the Royal Society of London Series B. Biological sciences. 2014; 369 (1652). doi: 10.1098/rstb.2013.0503 PMID: 25135964; PubMed Central PMCID: PMC4142024.
36. Ridder K, Keller S, Dams M, Rupp AK, Schlaudraff J, Del Turco D, et al. Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation. PLoS biology. 2014; 12(6):e1001874. doi: 10.1371/journal.pbio.1001874 PMID: 24893313; PubMed Central PMCID: PMC4043485.
37. Sun Y, Li Q, Gui H, Xu DP, Yang YL, Su DF, et al. MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines. Cell research. 2013; 23 (11):1270-83. doi: 10.1038/cr.2013.116 PMID: 23979021; PubMed Central PMCID: PMC3817544.
38. Bazzoni F, Rossato M, Fabbri M, Gaudiosi D, Mirolo M, Mori L, et al. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106(13):5282-7. doi: 10.1073/pnas.0810909106 PMID: 19289835; PubMed Central PMCID: PMC2664036.
39. Kamel H, Iadecola C. Brain-immune interactions and ischemic stroke: clinical implications. Archives of neurology. 2012; 69(5):576-81. doi: 10.1001/archneurol.2011.3590 PMID: 22782509; PubMed Central PMCID: PMC3586409.